Therefore, the HIF-1/EZH2 signaling can be sustained inside extremely aggressive breast cancer cells devoid of the estrogen receptor (ER−), leading to the proliferation, invasion, migration, and angiogenesis of breast cancer cells [46]. The gene discussed is EZH2; the disease is breast carcinoma.